The University of Miami Ear Institute (UMEI) was conceived and founded by Dr. W. Jarrard (Jerry) Goodwin in 1990, then Chairman of the University of Miami Department of Otolaryngology-Head and Neck Surgery. Dr. Goodwin's goal was to establish a state-of-the-art institution featuring world-renowned experts in otology, audiology, cochlear implants, balance disorders, skull base surgery, and research. With the support of many within and outside the University, he succeeded in this endeavor and appointed Thomas J. Balkany the first director of the Ear Institute. Under Dr. Balkany's leadership, the institute continued to evolve alongside the growing University of Miami Department of Otolaryngology, pioneering developments in pediatric cochlear implant surgery and postoperative care and basic science research. Dr. Balkany transitioned from UMEI Director in 2010, succeeded by Dr. Fred F. Telischi, and subsequently Dr. Simon I. Angeli who is the current Ear Institute Director. The Ear Institute experienced exponential growth in clinical services, research, education, and advocacy throughout the 2nd decade of the 21st century. Renamed the UHealth Ear Institute, its organizational structure evolved to meet new challenges. In its 34-year history, the UHealth Ear Institute has transformed from an idea into a nationally and internationally recognized center of excellence. It remains dedicated to advocating for universal hearing health, ensuring access to hearing health services, providing exceptional patient care, advancing innovative research, and training future specialists.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671097 | PMC |
http://dx.doi.org/10.1097/ONO.0000000000000063 | DOI Listing |
Adv Sci (Weinh)
January 2025
Department of Otolaryngology Head and Neck Surgery, Nanjing Drum Tower Hospital, Jiangsu Provincial Key Medical Discipline, Nanjing University Medical School, Nanjing, 210008, China.
Cisplatin-induced ototoxicity is attributed to the aberrant accumulation of reactive oxygen species (ROS) within the inner ear. Antioxidants represented by α-lipoic acid (ALA) have been demonstrated to scavenge ROS in the cochlea, while effective delivery of these agents in vivo remains a major challenge. Here, a novel polydopamine (PDA) nanogel decorated adhesive and responsive hierarchical microcarriers for controllable is presented ALA delivery and deafness prevention.
View Article and Find Full Text PDFPLOS Glob Public Health
January 2025
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Boston, Massachusetts, United States of America.
Endocr Oncol
January 2024
OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK.
Current models for the study of neuroendocrine tumours (NETs) are severely limited. While (e.g.
View Article and Find Full Text PDFFall armyworm (FAW, ) emerged as a major lepidopteran pest destroying maize in sub-Saharan Africa. A diallel mating design was used to generate 210 experimental hybrids from 21 lines. Experimental hybrids and four checks were evaluated in two locations.
View Article and Find Full Text PDFCogn Affect Behav Neurosci
January 2025
Aix Marseille Univ, Inserm, INS, Inst Neurosci Syst, Marseille, France.
Focusing on a single source within a complex auditory scene is challenging. M/EEG-based auditory attention detection (AAD) allows to detect which stream an individual is attending to within a set of multiple concurrent streams. The high interindividual variability in the auditory attention detection performance often is attributed to physiological factors and signal-to-noise ratio of neural data.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!